United States v. Rassan M. Tarabein

CourtCourt of Appeals for the Eleventh Circuit
DecidedJanuary 13, 2020
Docket18-13743
StatusUnpublished

This text of United States v. Rassan M. Tarabein (United States v. Rassan M. Tarabein) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Rassan M. Tarabein, (11th Cir. 2020).

Opinion

Case: 18-13743 Date Filed: 01/13/2020 Page: 1 of 11

[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT ________________________

No. 18-13743 Non-Argument Calendar ________________________

D.C. Docket No. 1:17-cr-00090-KD-MU-1

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

RASSAN M. TARABEIN,

Defendant-Appellant.

________________________

Appeal from the United States District Court for the Southern District of Alabama ________________________

(January 13, 2020)

Before MARTIN, BRANCH, and FAY, Circuit Judges.

PER CURIAM: Case: 18-13743 Date Filed: 01/13/2020 Page: 2 of 11

Rassan Tarabein appeals his $15,010,682 restitution calculation after he

pleaded guilty to one count of health care fraud, in violation of 18 U.S.C. § 1347,

and one count of unlawful distribution of controlled substances, in violation of 21

U.S.C. § 841(a)(1). On appeal, he argues that the district court plainly erred by not

making specific factual findings as to the calculation of restitution during the

sentencing hearing. After a thorough review of the record, we affirm.

I. Background

Rassan Tarabein was a licensed neurologist who provided services related to

pain management and neurology. For these services, he billed various health care

benefit programs, including government and private insurers. From around 2004

to May 2017, Tarabein orchestrated a scheme to defraud the health care benefit

programs by billing the programs for medically unnecessary tests and procedures.

Additionally, Tarabein distributed and dispensed controlled substances to patients

for no legitimate medical purpose and outside the usual course of professional

practice.

A federal grand jury indicted Tarabein with two counts of heath care fraud,

in violation of 18 U.S.C. § 1347, ten counts of false statements relating to health

care matters, in violation of 18 U.S.C. § 1035, one count of false statements to a

federal agency, in violation of 18 U.S.C. § 1001, four counts of unlawful

distribution of controlled substances, in violation of 21 U.S.C. § 841(a)(1), and

2 Case: 18-13743 Date Filed: 01/13/2020 Page: 3 of 11

four counts of engaging in monetary transactions in property derived from

specified unlawful activity, in violation of 18 U.S.C. § 1957.

Tarabein pleaded guilty to one count of health care fraud and one count of

unlawful distribution of controlled substances pursuant to a written plea agreement.

In the penalties section, the plea agreement contemplated “such restitution as may

be ordered by the court.” The agreement further noted that under 18 U.S.C §§

3556 and 3663(A) restitution was mandatory, and that “the defendant agrees to

make full restitution in an amount to be determined by the Court at sentencing.”

The government agreed to recommend a 60-month sentence. Additionally, the

plea agreement contained an appeal waiver, which provided that:

As part of the bargained-for exchange represented in this plea agreement, and subject to the limited exceptions below, the defendant knowingly and voluntarily waives the right to file any direct appeal or any collateral attack, including a motion to vacate, set aside, or correct sentence under 28 U.S.C. § 2255. Accordingly, the defendant will not challenge his guilty plea, conviction, or sentence in any district court or appellate court proceedings.

The agreement further provided that the only exceptions to the appeal waiver were

for (1) any sentence imposed in excess of the statutory maximum, (2) any sentence

which constitutes an upward departure or variance from the advisory guideline

range, or (3) a claim of ineffective assistance of counsel in a direct appeal or §

2255 motion.

3 Case: 18-13743 Date Filed: 01/13/2020 Page: 4 of 11

At the plea hearing, the district court then spoke specifically about the

appeal waiver. The court asked:

In the plea agreement, you are waiving your right to appeal the entry of this guilty plea as well as the sentence that I give you. You can’t file a direct appeal or a collateral appeal. Do you understand that? . . . The only exception is if I go above the guidelines, which I won’t do, if I go above the statutory maximum, which I won’t do, or if you receive ineffective assistance of counsel. Those would be the only reasons you could appeal the sentence or this conviction. Do you understand?

In response to both questions, Tarabein answered affirmatively that he understood

the terms of the appeal waiver.

The probation department prepared an initial presentence investigation

report (“PSI”) prior to Tarabein’s sentencing. The probation officer noted that the

Mandatory Victim Restitution Act of 1996 applied to Tarabein’s offense and

adopted the loss calculations of a special agent for the government, which then

formed the basis for the restitution amount. The report indicated that Tarabein was

accountable for $12,231,301 of illicit payments that he received from the health

care organizations.

Tarabein initially objected to the amount of restitution listed in the PSI. The

government also objected but argued that the total restitution amount should be

$14,526,122.63 because the figure listed in the PSI only included restitution for

fraudulent procedures when it should have included fraudulent prescriptions as

4 Case: 18-13743 Date Filed: 01/13/2020 Page: 5 of 11

well. Tarabein then withdrew his objections to the PSI and “adopt[ed] the

application and determination of sentencing factors and the guidelines calculations

contained therein.”

The final PSI revised the total restitution amount owed, determining that the

final amount was $15,010,682. This number included $12,715,860 of fraudulent

procedures and $2,524,794 of fraudulent schedule II prescriptions. The total did

not include the roughly four million dollars of fraudulent non-schedule II

prescriptions. However, the total did give Tarabein credit for refunds in the

amount of $229,973.

Prior to sentencing, the government filed a supplemental memorandum

detailing how an FBI special agent had calculated the loss amount and restitution

amount associated with Tarabein’s health care fraud scheme.1 The document

provided charts, explanations, and specifics on how the special agent calculated the

loss amount for each insurance company fraudulently billed.

At the sentencing hearing, the district court stated that the probation office

had determined Tarabein’s total offense level to be 33 with criminal history

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Futrell
209 F.3d 1286 (Eleventh Circuit, 2000)
United States v. Darrell B. Gresham
325 F.3d 1262 (Eleventh Circuit, 2003)
United States v. David Wayne Monroe
353 F.3d 1346 (Eleventh Circuit, 2003)
United States v. James T. Dickerson
370 F.3d 1330 (Eleventh Circuit, 2004)
United States v. Garland George Curtis
400 F.3d 1334 (Eleventh Circuit, 2005)
United States v. Carl Bennett
472 F.3d 825 (Eleventh Circuit, 2006)
United States v. Lopez
562 F.3d 1309 (Eleventh Circuit, 2009)
United States v. Tommie Huff
609 F.3d 1240 (Eleventh Circuit, 2010)
United States v. Bradley
644 F.3d 1213 (Eleventh Circuit, 2011)
United States v. Lineten Belizaire
774 F.3d 711 (Eleventh Circuit, 2014)
Roscoemanuel James Daniels v. United States
809 F.3d 588 (Eleventh Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Rassan M. Tarabein, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-rassan-m-tarabein-ca11-2020.